Young & Partners Forum Webcast: Operating in China in the Current Environmentdigitalstudios2022-10-17T14:04:17+00:00October 12th, 2022|Our Broadcasts|
Chemical M&A trends shift down (ICIS Chemical Business August 26 – September 1, 2022)digitalstudios2022-08-28T14:56:04+00:00August 26th, 2022|Featured|
Pharm Exec: Navigating the Financial Meltdown for Biopharma (Young & Partners article – August 2022 issue)digitalstudios2022-08-12T18:23:33+00:00August 12th, 2022|Featured|
Disruptions Suppress M&A and Financing (ICIS Chemical Business (May 20-26, 2022 issue)digitalstudios2022-08-28T14:56:31+00:00May 25th, 2022|Uncategorized|
Medical Device Industry Merger and Acquisition Trendsdigitalstudios2024-09-18T22:26:23+00:00April 16th, 2021|Issues & Trends, Medical Device Industry - Merger and Acquisition Trends|
Medical Device Industry Debt and Equity Financing Trendsdigitalstudios2024-09-18T22:27:23+00:00April 16th, 2021|Issues & Trends, Medical Device Industry - Debt and Equity Financing Trends|
Medical Device Industry Stock Market Trendsdigitalstudios2024-09-18T22:31:39+00:00March 5th, 2021|Issues & Trends, Medical Device Industry - Stock Market Trends|
Chemical Industry Financial Critical Massdigitalstudios2024-12-09T23:07:16+00:00March 5th, 2021|Chemical Industry - Financial Critical Mass, Issues & Trends|
Pharmaceutical Industry Stock Market Trendsdigitalstudios2024-10-14T18:42:22+00:00March 5th, 2021|Issues & Trends, Pharmaceutical Industry - Stock Market Trends|
Biotechnology Industry Stock Market Trendsdigitalstudios2024-10-14T18:36:52+00:00March 5th, 2021|Biotechnology Industry - Stock Market Trends, Issues & Trends|
